Results 71 to 80 of about 28,439 (272)

A case of pyoderma gangrenosum in a dog successfully treated with prednisolone alone [PDF]

open access: yes, 2015
In this case report, a markedly painful ulcerative dermatitis consistent with pyoderma granulosum is reported in a 2.5-year-old entire female Maltese dog.
Declercq, Jan
core   +1 more source

Gene therapy for pyoderma gangrenosum: optimal transfection conditions and effect of drugs on gene delivery in the HaCaT cell line using cationic liposomes [PDF]

open access: yes, 2016
Background/Aims: Pyoderma gangrenosum (PG) is a rare ulcerative skin disease, currently treated empirically with immunosuppression. PG is a good target for gene therapy since the skin is easily accessible.
Birchall, James Caradoc   +2 more
core   +2 more sources

A structured, behavioural science approach to the preparation of antimicrobial stewardship interventions for companion animal veterinarians

open access: yesVeterinary Record, EarlyView.
Abstract Background A structured, behavioural science approach was adopted to develop antimicrobial stewardship interventions in UK first‐opinion companion animal veterinary practice. The objectives were to identify behavioural targets for intervention and to understand how practice contexts influence these behaviours.
Ben Walker   +3 more
wiley   +1 more source

Scabies: Application of the Novel Identify-Isolate-Inform Tool for Detection and Management [PDF]

open access: yes, 2020
Scabies is a highly contagious, globally prevalent, parasitic skin infestation caused by Sarcoptes scabiei var. hominis, also known as the itch mite.
Al-Wabel, Abdussalam   +7 more
core  

Feasibility and acceptability of meticillin‐resistant Staphylococcus aureus biosecurity measures in equine facilities: A cross‐sectional study

open access: yesVeterinary Record, EarlyView.
Abstract Background Biosecurity measures are recommended in stables housing meticillin‐resistant Staphylococcus aureus (MRSA)‐positive horses, but their feasibility and acceptability, as well as their implementation barriers, remain unclear. Methods A cross‐sectional study was conducted among clients of a veterinary teaching hospital using an online ...
Pauline Planes   +3 more
wiley   +1 more source

Extra-gastrointestinal manifestations of inflammatory bowel disease may be less common than previously reported [PDF]

open access: yes, 2016
Extra-intestinal manifestations are well recognized in inflammatory bowel disease (IBD). To what extent the commonly recognized extra-intestinal manifestations seen in IBD patients are attributable to IBD is, however, not clear due to the limited number ...
B Hammer   +16 more
core   +3 more sources

Pyoderma Gangrenosum as a Presenting Feature of Undifferentiated Spondyloarthropathy with Erosive Inflammatory Arthritis

open access: yesCase Reports in Rheumatology, 2020
Pyoderma gangrenosum is a rare inflammatory condition with varying clinical presentations and severity. It is commonly seen in association with an underlying condition, most common of which is inflammatory bowel disease. We report a case of a 26-year-old
Jaspreet Kaler   +4 more
doaj   +1 more source

Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: Phenotype-genotype correlations [PDF]

open access: yes, 2005
AIM: To determine common NOD2/CARD15 mutations and TLR4 D299G polymorphism in Hungarian patients with CD. METHODS: A total of 527 unrelated patients with CD (male/female: 265/262, age: 37.1 (SD 7.6) years) and 200 healthy subjects were included.
Altorjay, István   +12 more
core   +1 more source

Update on Non‐Biological and RNA‐Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper

open access: yesAllergy, EarlyView.
ABSTRACT In the last decades, critical advancements in research technology and knowledge on disease mechanisms steered therapeutic approaches for chronic inflammatory diseases towards unprecedented target specificity. For allergic and chronic lung diseases, biologic drugs pioneered this goal, acquiring on the way—through the clinical use of monoclonal ...
F. Roth‐Walter   +20 more
wiley   +1 more source

Home - About - Disclaimer - Privacy